Xolair, Nucala, Duxepint, Fasenra
Xolair (omalizumab), a biologic agent that targets IGE, is used to treat moderate to severe asthma in ages 9 and above. Xolair is also used to treat chronic hives (idiopathic urticarial) in children and adults > age 12.
Nucala (mepolizumab) and Fasenera ( benralizumab) are newer biologic agents used to treat moderate to severe asthma in adults who have elevated eosinophil counts.
Dupixent (Dupilumab) is a new biologic agent used to treat adults with moderate to severe atopic dermatitis.